已知恶性肿瘤病史患者椎体强化术中活检结果的评估
影像怀疑恶性者91例,最终73例确诊恶性,恶性骨折发生率46.8%;影像提示骨质疏松者65例活检均阴性。影像评估敏感度100%、特异度78.3%。
要点
- 联合X线、CT和MRI可区分恶性与骨质疏松性椎体压缩骨折。
- 影像无恶性征象者,椎体强化术中无需常规活检。
- 影像怀疑恶性者,推荐术中行活检确认。
核心结论
- 联合X线、CT和MRI足以区分恶性与骨质疏松性椎体压缩骨折。
- 已知恶性肿瘤病史患者若影像无恶性征象,椎体强化术中无需活检确认。
- 术前影像怀疑恶性椎体压缩骨折者推荐行活检。
研究设计与样本
- 回顾性分析2012至2021年间行椎体强化术的椎体压缩骨折患者。
- 影像评估由肿瘤科医生、脊柱外科医生和放射科医生共同完成。
- 根据术前影像分为A组(怀疑恶性,91例)和B组(怀疑骨质疏松性,65例)。
关键影像表现/征象
- A组91例术前影像怀疑恶性椎体压缩骨折,最终73例经活检确诊恶性,影像与活检结果一致。
- B组65例影像提示骨质疏松性椎体压缩骨折,所有活检结果均为恶性阴性。
诊断标准与关键数值
- 影像评估诊断恶性椎体压缩骨折的敏感度为100%,特异度为78.3%。
- 恶性椎体压缩骨折发生率为46.8%。
临床应用与阅片要点
- 对已知恶性肿瘤病史的椎体压缩骨折患者,术前应联合X线、CT和MRI评估。
- 影像无恶性征象时,椎体强化术中可不行活检。
- 影像怀疑恶性时,术中应行活检以确认诊断。
局限性
- 研究为回顾性设计。
- 单中心研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate biopsy results during vertebral augmentation in vertebral compression fracture (VCF) patients with a known history of malignancy.
METHODS: An analysis of vertebral augmentation between 2012 and 2021 was performed retrospectively. Each level of VCF was biopsied, and all biopsies were sent for histopathological analyses. Imaging evaluation was performed in collaboration with an oncologist, a spine surgeon, and a radiologist. Patients were divided into two groups based on the preoperative imaging findings. Malignant VCF (MVCF) was presumed in group A, while osteoporotic VCF (OVCF) was presumed in group B.
RESULTS: One hundred and fifty-six VCF patients with a known history of malignancy were included. Group A included 91 patients with preoperative imaging findings suspicious for MVCF. And 73 patients were finally diagnosed as MVCF, with biopsy results confirming imaging findings. The incidence of MVCF was 46.8%. Group B included 65 patients with imaging evidence of OVCF. And all biopsy results were negative for malignancy. The sensitivity of imaging evaluation for finding MVCF was 100%, and the specificity was 78.3%.
CONCLUSION: A combination of X-ray, computed tomography (CT), and magnetic resonance imaging (MRI) is sufficient to distinguish MVCF from OVCF. Biopsy is not required to confirm the diagnosis during vertebral augmentation, if the imaging findings do not indicate MVCF in patients with a known history of malignancy. It is recommended to perform a biopsy in patients with preoperative imaging findings suspicious for MVCF.
KEY POINTS: • A combination of X-ray, CT, and MRI is sufficient to distinguish MVCF from OVCF. • Biopsy is not required in patients without imaging signs of MVCF. • Biopsy is recommended in patients with imaging findings suspicious for MVCF.
引用
- Jia, Chen, Wang, et al. Evaluation of biopsy results during vertebral augmentation in patients with a known history of malignancy. Eur Radiol. 2022. PMID: 36478121. doi:10.1007/s00330-022-09291-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。